Armstrong Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
PCA
MSV
BTCPP
VFA
CAM
EB
AIM
FFA
QPBE
Armstrong Advisory Group's LLY Position: Q3 2026 in Review
Armstrong Advisory Group increased its Eli Lilly (LLY) stake by 1.5% in Q3 2026, buying an estimated $120K and bringing the position to 6,825 shares worth $7.9M. The position accounts for 0.48% of the portfolio, ranked #26.
Armstrong Advisory Group first reported a position in LLY in Q4 2022 and has held it in 16 quarters since. The position peaked at $8.8M in Q4 2025. 255 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Armstrong Advisory Group held 6,825 shares of Eli Lilly worth $7.9M as of Q3 2026.
- Armstrong Advisory Group bought 102 Eli Lilly shares in Q3 2026, an estimated $120K.
- Eli Lilly made up 0.48% of Armstrong Advisory Group's portfolio in Q3 2026, its #26 holding.
- Armstrong Advisory Group first reported a position in Eli Lilly in Q4 2022 and has held it in 16 quarters since.
- Armstrong Advisory Group's Eli Lilly position peaked at $8.8M in Q4 2025.
- 255 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.